clinical trial · NCT07339358
Safety & Performance of the World Medica World Diverter Embolization Device
World Medica USA, LLC·N/A·not yet recruiting·n = 72
Intracranial AneurysmFlow diverter implantation
brief summary
The objective of this study is to investgiate the safety and clinical performance of the World Diverter Emoblization Device for the endovascular treatment of wide-neck (neck width ≥ 4 mm or dome-to-neck ratio \<2) or fusiform intracranial aneurysms in the internal carotid artery (ICA) from the petrous segment to the terminus arising from a parent vessel with a diameter ≥ 2.5 mm and ≤ 5.5 mm.
started
Mar 31, 2026
primary completion
Mar 31, 2028
completion
Aug 31, 2028
last updated
Jan 14, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol